Bristol Price on June 3, 2020 Breakdown

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>BM</div>
BMY -- USA Stock  

Report: 6th of August 2020  

Bristol Myers stock price history is provided at the adjusted bases, taking into account all of the recent filings. As of today the current price of Bristol Myers is  57.43 , as last reported on the 10th of July, with the highest price reaching  58.09  and the lowest price hitting  57.16  during the day. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of -0.0079, which signifies that the company had -0.0079% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Bristol Myers Squibb exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bristol Myers Squibb downside deviation of 1.56, mean deviation of 1.1, and risk adjusted performance of 0.0186 to double-check the risk estimate we provide.

Search Stock Price History

 
Refresh
Net Income Common Stock is likely to drop to about 3.3 B in 2020. Price to Book Value is likely to grow to 2.08 in 2020. Price to Earnings Ratio is likely to grow to 37.29 in 2020.

Date Headline

Bristol Myers Headline on 3rd of June 2020

Filed transaction by Bristol Myers Squibb Co director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Bristol Myers Valuation Near June 3, 2020

 Open High Low Close Volume
  60.29    60.68    59.27    60.65    15,426,443  
 06/03/2020 
  60.70    60.89    59.69    60.21    13,437,313  
  59.82    61.09    59.82    60.89    13,446,313  
Backtest Bristol Myers  |  Bristol Myers History  |  Bristol Myers Valuation   PreviousNext  
Open Value
60.7
3rd of June 2020
 
60.21
Closing Value
65.06
Upside
 

Bristol Myers Trading Date Momentum on June 3, 2020

On June 04 2020 Bristol Myers Squibb was traded for  60.89  at the closing time. Highest Bristol Myers's price during the trading hours was 61.09  and the lowest price during the day was  59.82 . The net volume was 13.4 M. The overall trading history on the 4th of June contributed to the next trading period price jump. The overall trading delta to the next next day price was 1.13% . The overall trading delta to current price is 7.59% .

Bristol Myers Squibb Fundamentals Correlations and Trends

About Bristol Myers Stock history

Bristol Myers investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bristol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bristol Myers Squibb will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bristol Myers historical stock prices may prove useful in developing a viable investing in Bristol Myers
Last ReportedProjected for 2020
Weighted Average Shares1.6 B1.6 B
Weighted Average Shares Diluted1.7 B1.9 B
Issuance Purchase of Equity Shares-7.3 B-7.5 B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug ManufacturersGeneral classification in the United States and is traded on BATS Exchange. It employs 30000 people.

Bristol Myers Stock Technical Analysis

Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bristol Myers technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bristol Myers trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Bristol Myers Period Price Range

Low
June 3, 2020
High
 60.70 
  
 60.21 
-0.49-0.81%

Bristol Myers July 10, 2020 Market Strength

Bristol Myers Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bristol stock's direction in advance. Along with the technical and fundamental analysis of Bristol Myers historical stock price patterns, it is also worthwhile for investors to track various predictive indicators of Bristol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance0.0186
Jensen Alpha0.0329
Total Risk Alpha(0.12)
Sortino Ratio(0.1)
Treynor Ratio(0.042729)
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Continue to Trending Equities. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page